AI assistant
Sending…
EXELON CORP — Director's Dealing 2023
Jan 4, 2023
30044_dirs_2023-01-04_58b22948-3897-459c-9d4d-1c44da7c5f26.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2022-12-31
Reporting Person: Cheshire Marjorie Rodgers (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | Common Stock (Deferred Stock Units) | A | 936 | $41.42 | Acquired | 10380 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | Deferred Compensation - Phantom Share Equivalents | $ | A | 335 | Acquired | Common Stock (335) | Direct |
Footnotes
F1: Balance includes 76 shares acquired on December 9, 2022 through automatic dividend reinvestment.
F2: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 28 share equivalents accrued on November 14, 2022 through automatic dividend reinvestment.
More from EXELON CORP
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 16
Annual Report
2026
Mar 18
Regulatory Filings
2026
Mar 18
Proxy Solicitation & Information Statement
2026
Mar 18
Regulatory Filings
2026
Feb 20
Regulatory Filings
2026
Feb 12
Annual Report
2026
Feb 12
Director's Dealing
2026
Feb 4